Shopping Cart
- Remove All
Your shopping cart is currently empty
GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.GAC0003A4 has been used in the study of advanced pancreatic cancers and other recalcitrant malignancies.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $67 | In Stock | |
| 5 mg | $167 | In Stock | |
| 10 mg | $265 | In Stock | |
| 25 mg | $440 | In Stock | |
| 50 mg | $620 | In Stock | |
| 100 mg | $833 | In Stock | |
| 200 mg | $1,120 | In Stock |
| Description | GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.GAC0003A4 has been used in the study of advanced pancreatic cancers and other recalcitrant malignancies. |
| Synonyms | GAC0001E5 |
| Molecular Weight | 340.42 |
| Formula | C20H24N2O3 |
| Cas No. | 929492-71-7 |
| Smiles | C(=O)(C1=CC(OC)=CC(OC)=C1)N2CCN(CC2)C3=C(C)C=CC=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (235.00 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.